Abstract IA009: Epigenetic approaches to endometriosis-associated ovarian cancer

Rugang Zhang
DOI: https://doi.org/10.1158/1538-7445.ovarian23-ia009
IF: 11.2
2024-03-05
Cancer Research
Abstract:The past decade has brought unprecedented progress in understanding the genetics of epithelial ovarian cancer (EOC), but cures remain elusive due to the lack of insights into mechanisms that can be leveraged to develop new therapies. EOC is genetically heterogeneous and, therefore, it is imperative that therapeutic strategies become personalized by targeting distinct molecular subsets of EOC. Despite the importance of epigenetic regulators in EOC, the mechanism of action for these epigenetic regulators and the associated vulnerabilities exposed by their dysregulations have remained elusive for most of them. Here we will discuss our recent work on how to leverage epigenetic mechanisms to address unmet clinical needs in endometriosis-associated ovarian cancer through integrated approaches. Citation Format: Rugang Zhang. Epigenetic approaches to endometriosis-associated ovarian cancer [abstract]. In: Proceedings of the AACR Special Conference on Ovarian Cancer; 2023 Oct 5-7; Boston, Massachusetts. Philadelphia (PA): AACR; Cancer Res 2024;84(5 Suppl_2) nr IA009.
oncology
What problem does this paper attempt to address?